↓ Skip to main content

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

Overview of attention for article published in The Lancet, June 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#27 of 36,698)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Citations

dimensions_citation
510 Dimensions

Readers on

mendeley
1230 Mendeley
Title
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Published in
The Lancet, June 2020
DOI 10.1016/s0140-6736(20)31208-3
Pubmed ID
Authors

Feng-Cai Zhu, Yu-Hua Li, Xu-Hua Guan, Li-Hua Hou, Wen-Juan Wang, Jing-Xin Li, Shi-Po Wu, Bu-Sen Wang, Zhao Wang, Lei Wang, Si-Yue Jia, Hu-Dachuan Jiang, Ling Wang, Tao Jiang, Yi Hu, Jin-Bo Gou, Sha-Bei Xu, Jun-Jie Xu, Xue-Wen Wang, Wei Wang, Wei Chen

Twitter Demographics

The data shown below were collected from the profiles of 7,837 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 1,230 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1230 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 177 14%
Researcher 151 12%
Student > Master 127 10%
Student > Ph. D. Student 117 10%
Other 91 7%
Other 257 21%
Unknown 310 25%
Readers by discipline Count As %
Medicine and Dentistry 299 24%
Biochemistry, Genetics and Molecular Biology 138 11%
Immunology and Microbiology 71 6%
Agricultural and Biological Sciences 68 6%
Pharmacology, Toxicology and Pharmaceutical Science 65 5%
Other 228 19%
Unknown 361 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 6996. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2021.
All research outputs
#200
of 17,638,294 outputs
Outputs from The Lancet
#27
of 36,698 outputs
Outputs of similar age
#48
of 293,342 outputs
Outputs of similar age from The Lancet
#7
of 391 outputs
Altmetric has tracked 17,638,294 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 36,698 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 55.6. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 293,342 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 391 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.